AU4459797A - Peptide as diagnostic and therapeutic agent for autoimmune diseases - Google Patents

Peptide as diagnostic and therapeutic agent for autoimmune diseases

Info

Publication number
AU4459797A
AU4459797A AU44597/97A AU4459797A AU4459797A AU 4459797 A AU4459797 A AU 4459797A AU 44597/97 A AU44597/97 A AU 44597/97A AU 4459797 A AU4459797 A AU 4459797A AU 4459797 A AU4459797 A AU 4459797A
Authority
AU
Australia
Prior art keywords
peptide
diagnostic
therapeutic agent
autoimmune diseases
autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44597/97A
Inventor
Gerhild Wildner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU4459797A publication Critical patent/AU4459797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU44597/97A 1996-09-18 1997-09-18 Peptide as diagnostic and therapeutic agent for autoimmune diseases Abandoned AU4459797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19638108 1996-09-18
DE19638108 1996-09-18
PCT/EP1997/005124 WO1998012221A1 (en) 1996-09-18 1997-09-18 Peptide as diagnostic and therapeutic agent for autoimmune diseases

Publications (1)

Publication Number Publication Date
AU4459797A true AU4459797A (en) 1998-04-14

Family

ID=7806049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44597/97A Abandoned AU4459797A (en) 1996-09-18 1997-09-18 Peptide as diagnostic and therapeutic agent for autoimmune diseases

Country Status (8)

Country Link
EP (1) EP0950065B1 (en)
JP (2) JP4615630B2 (en)
CN (1) CN1227263C (en)
AU (1) AU4459797A (en)
DE (1) DE59709363D1 (en)
ES (1) ES2193401T3 (en)
HK (1) HK1024006A1 (en)
WO (1) WO1998012221A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810099D0 (en) * 1998-05-11 1998-07-08 Isis Innovation Novel molecule and diagnostic method
ES2290171T3 (en) * 2000-08-14 2008-02-16 N.V. Organon USE OF ANTIBODIES AGAINST COMPLEX SPECIFIC MCH PEPTIDES.
WO2009090651A2 (en) * 2008-01-15 2009-07-23 Technion Research And Development Foundation Ltd. Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
EP3016968B1 (en) * 2013-07-01 2019-06-26 Newsouth Innovations Pty Limited Diagnosis and treatment of autoimmune diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5719064A (en) * 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
CA2176208A1 (en) * 1993-11-10 1995-05-18 Carol Clayberger Surface membrane proteins and their effect on immune response

Also Published As

Publication number Publication date
WO1998012221A1 (en) 1998-03-26
ES2193401T3 (en) 2003-11-01
EP0950065A1 (en) 1999-10-20
DE59709363D1 (en) 2003-03-27
JP2010235607A (en) 2010-10-21
CN1237981A (en) 1999-12-08
JP2001504451A (en) 2001-04-03
CN1227263C (en) 2005-11-16
JP4615630B2 (en) 2011-01-19
EP0950065B1 (en) 2003-02-19
HK1024006A1 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
AU7383298A (en) Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
AU9383098A (en) Novel targeted contrast agents for diagnostic and therapeutic use
AU5721798A (en) Human mage-like protein
AU7378198A (en) Therapeutic ultrasound system
AU4397297A (en) Antibody against human parathormone related peptides
AU2789397A (en) Diagnostic drugs for autoimmune diseases
AU3816697A (en) Conservin compositions and therapeutic and diagnostic uses therefor
AU4463996A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU5796298A (en) Secreted human proteins
AU2557997A (en) Human cachexia associated protein
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
HUP9900147A3 (en) Therapeutic agents and autoimmune diseases
AU5389096A (en) Human hematopoietic-specific protein
AU2976597A (en) Autoimmune disease therapeutic agent
AU4480697A (en) Human nm23-like protein
IL129024A0 (en) Use of proteins as agent against autoimmune diseases
AU7141698A (en) Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU6517398A (en) Therapeutic agent for autoimmune diseases
AU4459797A (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
AU6961298A (en) Therapeutic compositions and diagnostic assays for diseases involving trbp
AU5148098A (en) Human eosinophil-derived basic protein
AU4705201A (en) Peptide constructs for treating autoimmune and related diseases
EP0878200A4 (en) Therapeutic agent for ophthalmic diseases